New NIH-Funded Study Links Long-Term Use of Actos to Development of Bladder Cancer, the Consumer Justice Foundation Reports

Share Article

The Consumer Justice Foundation, a for-profit corporation whose team of professional advocates follow the mission of providing free online informational resources to individuals regarding the potential dangers of using certain prescription medications and it has a Web site that can be located at the URL of http://www.sideeffectsrx.com. The CJF hereby alerts the public of the release of the results of a study funded by the National Institutes of Health that concludes that long-term use of Actos for treatment of diabetes increases the risk of the development of bladder cancer. The results of this study were published in the Journal of the National Cancer Institute in its August, 2012 issue.

Our study shows that doctors who care for patients with diabetes should be very aware of any bladder-related symptoms patients might be having, like blood in the urine, and take steps to further evaluate those issues.

The Consumer Justice Foundation, a for-profit corporation whose team of consumer advocates provide free educational resources regarding the potential risks associated with using certain medications hereby alerts the public of the results of a new study that were recently published regarding the potential dangers of using Actos, a diabetes medication. These dangers involve the risk of developing bladder cancer in those patients who use Actos for a prolonged period of time.

The study, which was published in the August, 2012 issue of the Journal of the National Cancer Institute, was performed by researchers at the Perelman School of Medicine at the University of Pennsylvania and it was led by Dr. Ronac Mamtani. The study looked at 60,000 type 2 diabetes patients from The Health Improvement Network (THIN) database in the United Kingdom and focused on the differences between those patients who used thiazolidinedione and sulfonylurea drugs.

Based on that data, the researchers found that 170 patients per 100,000 who used thiazolidinedione for five or more years developed bladder cancer. This compared to 60 patients per 100,000 who used sulfonylurea drugs. The study was funded by the National Institutes of Health and is the first to compare the results of using these two different forms of medication.

“Our study shows that doctors who care for patients with diabetes should be very aware of any bladder-related symptoms patients might be having, like blood in the urine, and take steps to further evaluate those issues,” stated Dr. Mamtani. The study went on to caution that patients who have questions regarding the use of Actos should not hesitate to ask them before they take on any risk of developing Actos side effects.

About the Consumer Justice Foundation    

The Consumer Justice Foundation, whose Web site can be found at http://www.consumerjusticefoundation.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Faith Anderson
Visit website